Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
Atopic dermatitis (AD) is characterized by chronic, eczematous, severe pruritic skin lesions. The knowledge on the pathogenesis of AD is driving the development of new drugs. From the research results, it has been revealed that Th2 cell-mediated immunity, skin barrier dysfunction, and pruritus cause...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2022-01-01
|
| coleção: | Allergology International |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1323893021001398 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|